The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sigua B.V.

Almazov National Medical Research Center

Levchenko E.I.

City Multidisciplinary Hospital No. 2

Mavidi I.P.

City Multidisciplinary Hospital No. 2

Semenova E.A.

State Electrotechnical University «LETI»

Orlov O.Yu.

Elizabeth Hospital

Zemlyanoy V.P.

Mechnikov North-West State Medical University

Objective assessment of the risk of developing acute post-manipulation pancreatitis after endoscopic interventions in patients with choledocholithiasis

Authors:

Sigua B.V., Levchenko E.I., Mavidi I.P., Semenova E.A., Orlov O.Yu., Zemlyanoy V.P.

More about the authors

Journal: Endoscopic Surgery. 2025;31(2): 26‑34

Read: 869 times


To cite this article:

Sigua BV, Levchenko EI, Mavidi IP, Semenova EA, Orlov OYu, Zemlyanoy VP. Objective assessment of the risk of developing acute post-manipulation pancreatitis after endoscopic interventions in patients with choledocholithiasis. Endoscopic Surgery. 2025;31(2):26‑34. (In Russ.)
https://doi.org/10.17116/endoskop20253102126

Recommended articles:
Risk factors of post-ERCP complications: a single-center retrospective study. Piro­gov Russian Journal of Surgery. 2025;(8):15-22

References:

  1. Shapovalyants SG, Fedorov ED, Budzinsky SA, Kotieva AYu. Pancreatic duct stenting in the treatment of acute pancreatitis after endoscopic transpapillary interventions. Annals of surgical hepatology. 2014;19(1):17-28. (In Russ.).
  2. Shapovalyants SG, Gabriel SA, Dynko VYu, Kotieva AYu, Mamishev AK, Bespechny MV. Acute post-manipulation pancreatitis: diagnosis, risk factors, methods of prevention. Endoscopic surgery. 2020;26(4):49-53. (In Russ.). https://doi.org/10.17116/endoskop20202604149
  3. Gabriél’ SA, Durleshter VM, Dyn’ko VIu, Gol’fand VV. Endoscopic transpapillary interventions in diagnostics and treatment of patients with diseases of the pancreatobiliary area. Pirogov Russian Journal of Surgery. 2015;(1):30-34. (In Russ.). https://doi.org/10.17116/hirurgia22015130-34
  4. Burdyukov MS, Nechipay AM. Choledocholithiasis: literature review. Evidence-based gastroenterology. 2020;9(4):55-66. (In Russ.). https://doi.org/10.17116/dokgastro2020904155
  5. Ko CW, Lee SP. Epidemiology and natural history of common bile duct stones and prediction of disease. Gastrointest Endosc. 2002;56:S165-S169.
  6. Molvar C, Glaenzer B. Choledocholithiasis: Evaluation, Treatment, and Outcomes. Semin Intervent Radiol. 2016;33(4):268-276.  https://doi.org/10.1055/s-0036-1592329
  7. Gerbali OYu, Puchkov KV, Puchkov DK. Variants of the clinical course of PCES with concomitant diseases of the abdominal organs. Endoscopic surgery. 2015;2:27-29. (In Russ.). https://doi.org/10.17116/endoskop201521226-29
  8. Sayfutdinov IM, Slavin LE, Galimzyanov AF, Sangadzhiev SB, Yakhin RR, Zamaleev AZ, Podshivalov AG, Baitimirov AM. New technologies to ensure the safety of endopapillary interventions in patients with choledocholithiasis. Practical medicine. 2018;9:56-61. (In Russ.).
  9. Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, Barthet M, Domagk D, Dumonceau JM, Gigot JF, Hritz I, Karamanolis G, Laghi A, Mariani A, Paraskeva K, Pohl J, Ponchon T, Swahn F, Ter Steege RWF, Tringali A, Vezakis A, Williams EJ, van Hooft JE. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51:472-491. 
  10. Chathadi KV, Chandrasekhara V, Acosta RD, Decker GA, Early DS, Eloubeidi MA, Evans JA, Faulx AL, Fanelli RD, Fisher DA, Foley K, Fonkalsrud L, Hwang JH, Jue TL, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Shaukat A, Shergill AK, Wang A, Cash BD, DeWitt JM. The role of ERCP in benign diseases of the biliary tract, American Society of Gastrointestinal Endoscopy (ASGE) guideline. Gastrointest Endosc. 2015;81(4):795-803.  https://doi.org/10.1016/j.gie.2014.11.019
  11. Testoni PA, Giussani A, Vailati C. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105(8):1753-1761.
  12. Testoni PA, Mariani A, Aabakken L, Arvanitakis M, Bories E, Costamagna G, Deviere J, Dinis-Ribeiro M, Dumonceau J-M, Giovannini M, Gyokeres T, Hafner M, Halttunen J, Hassan C, Lopes L, Papanikolaou IS, Tham TC, Tringali A, van Hooft J, Williams EJ. Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2016;48(7):657-683.  https://doi.org/10.1055/s-0042-108641
  13. Colton JB, Curran CC. Quality indicators, including complications of ERCP in a community setting: a prospective study. Gastrointest Endosc. 2009;70(3):457-467. 
  14. Baron T, Irani S Prevention of post-ERCP pancreatitis. Minerva Med. 2014;105(2):129-136. 
  15. Mohamed R, Cord Lethebe B, Gonzalez-Moreno E, Kayal A, Bass S, Cole1 M, Turbide C, Chau M, Koury HF. Morphology of the major papilla predicts ERCP procedural outcomes and adverse events. Surg Endosc. 2021;35(12):6455-6465. https://doi.org/10.1007/s00464-020-08136-9
  16. Kubiliun NM, Elmunzer BJ. Preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 2013;23(4):769-786.  https://doi.org/10.1016/j.giec.2013.06.003
  17. Dumonceau JM, Andriulli A, Deviere J. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42(6):503-515. 
  18. Cai JS, Qiang S, Bao-Bing Y. Advances of recurrent risk factors and management of choledocholithiasis. Scand J Gastroenterol. 2016;52(1):34-43.  https://doi.org/10.1080/00365521.2016.1224382
  19. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59:845-864. 
  20. Rosa B, Carvalho PB, Dias de Castro F. Sa1194 impact of intensive hydration on the incidence of post-ERCP pancreatitis: double-blinded randomized controlled trial. Gastrointest Endosc. 2016;83:AB250.
  21. Smeets XJNM, da Costa DW, Besselink MG, Bruno MJ, Fockens P, Mulder CJJ, van der Hulst RW, Vleggaar FP, Timmer R, Drenth JPH, van Geenen EJM. Systematic review: periprocedural hydration in the prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther. 2016;44:541-553.  https://doi.org/10.1111/apt.13744
  22. Popova MA, Leontyev AS, Korotkevich AG, Merzlyakov MV, Shestak IS. Post-manipulation pancreatitis: Relevance of the problem, diagnostic difficulties and unresolved issues. Polytrauma. 2018;3:86-106. (In Russ.).
  23. Saharia PC, Zuidema GD, Cameron JL. Primary common duct stones. Ann Surg. 1977;185:598-604.  https://doi.org/10.1097/00000658-197705000-00013
  24. Wu Y, Xu CJ, Xu SF. Advances in Risk Factors for Recurrence of Common Bile Duct Stones. Int J Med Sci. 2021;18(4):1067-1074. https://doi.org/10.7150/ijms.52974
  25. Akhter A, Pfau PR, Gopal DV. Rectal indomethacin to prevent post-ERCP pancreatitis. Gastroenterology. 2016;151:568-569. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.